無料セミナー : 2019年11月19日『手術用ロボット:外科医療におけるトランスフォーメーション』 BIS Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

NGSサンプル調製の世界市場:製品・ワークフロー・治療領域・アプリケーション・エンドユーザーへの注目 (2025年までの予測)

Global NGS Sample Preparation Market: Focus on Product (Workstation, Standalone, Consumables), Workflow, Therapy Area, Application, End User - Forecast to 2025

発行 BIS Research Inc. 商品コード 913746
出版日 ページ情報 英文 247 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
NGSサンプル調製の世界市場:製品・ワークフロー・治療領域・アプリケーション・エンドユーザーへの注目 (2025年までの予測) Global NGS Sample Preparation Market: Focus on Product (Workstation, Standalone, Consumables), Workflow, Therapy Area, Application, End User - Forecast to 2025
出版日: 2019年09月30日 ページ情報: 英文 247 Pages
概要

世界のNGS (次世代シーケンシング) サンプル調製市場は、2019年から2025年にかけて15.54%のCAGR (年間複合成長率) で拡大すると予測されています。

当レポートでは、世界のNGS (次世代シーケンシング) サンプル調製市場について調査分析し、市場力学、競合情勢、産業分析、セグメント別の市場分析と予測、地域別分析、主要企業について、体系的な情報を提供しています。

913746_2.2_Figure 2.1 Global NGS Sample Preparation Market, 2018-2025

エグゼクティブサマリー

第1章 調査範囲・手法

第2章 市場概要

第3章 市場力学

  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第4章 自動NGSサンプル調製市場:産業の考察

  • 主な発展
  • 産業動向

第5章 次世代シーケンシングサンプル調製市場、エンドユーザーおよび価格分析

  • 各種装置の満足度:ブランド別
  • 好みの製品の価格分析:ステップごと (サンプル定量、ライブラリー調製、ターゲットエンリッチメント、ライブラリー定量)
  • 価格分析:付属品・コンポーネント
  • 価格分析:消耗品

第6章 NGSサンプル調製市場:製品別

  • 自動ワークステーション
  • スタンドアローンオートメーション装置
  • 消耗品
  • 付属品・コンポーネント

第7章 NGSサンプル調製市場:ワークフロー別

  • サンプル調製/分離
  • サンプル定量
  • 品質管理
  • フラグメンテーション
  • ライブラリー調製
  • ターゲットエンリッチメント
  • ライブラリー定量
  • プーリング

第8章 NGSサンプル調製市場:治療領域別

  • 人類遺伝学/集団遺伝学
  • 出生前/新生児
  • 感染症
  • その他

第9章 NGSサンプル調製市場:用途別

  • DNAシーケンシング
  • 全ゲノムシーケンシング
  • RNAシーケンシング
  • メチル化シーケンシング
  • メタゲノミクス
  • シングルセルシーケンシング
  • その他

第10章 NGSサンプル調製市場:エンドユーザー別

  • 病院・クリニック
  • 大学・研究機会
  • 医薬品・バイオテクノロジー企業
  • その他のエンドユーザー

第11章 NGSサンプル調製市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第12章 競合情勢

  • 市場シェア分析
  • 製品ベンチマーキング
  • 成長シェア分析:エンドユーザー別
  • 成長シェア分析:地域別
  • 成長シェア分析:製品別

第13章 戦略提言

第14章 企業プロファイル

  • Agilent Technologies
  • Aurora Biomed Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eppendorf AG
  • F. Hoffmann-La Roche Ltd
  • Hamilton Company
  • Illumina, Inc.
  • New England Biolabs, Inc
  • Oxford Nanopore Technologies Limited
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Swift Biosciences Inc.
  • Tecan Group
  • Thermo Fisher Scientific Inc.
図表

List of Tables

  • Table 5.1: Pricing Analysis of Market Available Consumables
  • Table 6.1: Global NGS Sample Preparation Market Size (by Product), $Million, 2018-2025
  • Table 13.1: Major Issues in Research Laboratories in the Asia-Pacific Region
  • Table 13.2: Funding Scenario

List of Figures

  • Figure 1: Impact of Market Drivers and Market Restraints on the Global NGS Sample Preparation Market
  • Figure 2: NGS Sample Preparation Market (by Product), 2018 vs 2025, $Million
  • Figure 3: NGS Sample Preparation Market (by Application), 2018 vs 2025, $Million
  • Figure 4: NGS Sample Preparation Market (by End-User), 2018 vs 2025, $Million
  • Figure 5: Global NGS Sample Preparation Market Snapshot
  • Figure 1.1: Global NGS Sample Preparation Market Segmentation
  • Figure 1.2: Global NGS Sample Preparation Market Research Methodology
  • Figure 1.3: Primary Research
  • Figure 1.4: Secondary Research
  • Figure 1.5: Data Triangulation
  • Figure 1.6: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 1.7: Top-Down Approach (Segment-Wise Analysis)
  • Figure 1.8: Assumptions and Limitations
  • Figure 1.9: Considered Factors for Data Prediction and Modelling
  • Figure 2.1: Global NGS Sample Preparation Market, 2018-2025
  • Figure 3.1: Market Dynamics of Global NGS Sample Preparation Market
  • Figure 3.2: People Suffering from CF (Cystic Fibrosis), 2002-2017:
  • Figure 3.3: Number of Deaths by Top 18 Infectious Diseases, 2015
  • Figure 3.4: China Healthcare Expenditure (% of GDP), 2010-2016:
  • Figure 4.1: Share of Key Developments and Strategies
  • Figure 4.2: Product Launches Share (by Company), 2016 - 2019
  • Figure 4.3: Collaborations, Partnerships, and Agreements Share (by Company), 2016 - 2019
  • Figure 4.4: Product Enhancement Share (by Company), 2016 - 2019
  • Figure 4.5: Acquisitions Share (by Company), 2016 - 2019
  • Figure 4.6: Business Expansions Share (by Company), 2016 - 2019
  • Figure 5.1: NGS Sample Preparation Customer Preference (by Major Brand) (N=36)
  • Figure 5.2: NGS Sample Preparation Customer Satisfaction Level (5 being the highest) (by Brand) (N=36)
  • Figure 6.1: NGS Sample Preparation Market (by Product), $Million, 2019 and 2025,
  • Figure 6.2: Automated Workstations Market, $Million, 2018-2025
  • Figure 6.3: Open System Workstations Market, $Million ,2018-2025
  • Figure 6.4: Closed System Workstations Market, $Million, 2018-2025
  • Figure 6.5: Automated Workstations Market, $Million, 2018-2025
  • Figure 6.6: Fragment Analyzer Market, $Million, 2018-2025
  • Figure 6.7: Ultrasonicator/ Sonicator Market, $Million, 2018-2025
  • Figure 6.8: DNA/RNA Shearing Instruments Market, $Million, 2018-2025
  • Figure 6.9: Template Preparation Instruments Market, $Million, 2018-2025
  • Figure 6.10: DNA Selection Instruments Market, $Million, 2018-2025
  • Figure 6.11: Nucleic Acid Extraction/Isolation System Market, $Million, 2018-2025
  • Figure 6.12: NGS Sample Preparation Consumables Market, $Million, 2018-2025
  • Figure 6.13: NGS Sample Extraction and Isolation Kits Market, $Million, 2018-2025
  • Figure 6.14: NGS Sample Purification Kits Market, $Million, 2018-2025
  • Figure 6.15: NGS Library Preparation Kits Market, $Million, 2018-2025
  • Figure 6.16: NGS DNA Library Preparation Kits Market, $Million, 2018-2025
  • Figure 6.17: NGS RNA Library Preparation Kits Market, $Million, 2018-2025
  • Figure 6.18: FFPE DNA Kits Market, $Million, 2018-2025
  • Figure 6.19: ChIP-Sequencing Library Preparation Market, $Million, 2018-2025
  • Figure 6.20: Library Quantitation Market,$Million, 2018-2025
  • Figure 6.21: Library Amplification Market, $Million, 2018-2025
  • Figure 6.22: Library Preparation Accessories Market, $Million, 2018-2025
  • Figure 6.23: NGS Clean-Up and Selection Kits Market, $Million, 2018-2025
  • Figure 6.24: Target Enrichment Market, $Million, 2018-2025
  • Figure 6.25: Microbiome DNA Enrichment Market, $Million, 2018-2025
  • Figure 6.26: Other Consumables Market, $Million, 2018-2025
  • Figure 6.27: NGS Sample Preparation Consumables Market, $Million, 2018-2025
  • Figure 7.1: NGS Sample Preparation Market (by Workflow), $Million, 2019 and 2025
  • Figure 7.2: Sample Extraction/Isolation Market, $Million, 2018-2025
  • Figure 7.3: Sample Quantification Market, $Million, 2018-2025
  • Figure 7.4: Quality Control Market, $Million, 2018-2025
  • Figure 7.5: Fragmentation Market, $Million, 2018-2025
  • Figure 7.6: Library Preparation Market, $Million, 2018-2025
  • Figure 7.7: Target Enrichment Market, $Million, 2018-2025
  • Figure 7.8: Library Quantification Market, $Million, 2018-2025
  • Figure 7.9: Sample Pooling Market, $Million, 2018-2025
  • Figure 8.1: NGS Sample Preparation Market (by Therapeutic Area), $Million, 2019 and 2025
  • Figure 8.2: NGS Oncology Sample Preparation Market, $Million, 2018-2025
  • Figure 8.3: NGS Human Genetics/Population Genetics Sample Preparation Market, $Million, 2018-2025
  • Figure 8.4: NGS Prenatal/Neonatal Sample Preparation Market, $Million, 2018-2025
  • Figure 8.5: NGS Prenatal/Neonatal Sample Preparation Market, $Million, 2018-2025
  • Figure 8.6: NGS Other Therapeutic Areas Sample Preparation Market, $Million, 2018-2025
  • Figure 9.1: NGS Sample Preparation Market (by Application), $Million, 2019 and 2025
  • Figure 9.2: NGS Sample Preparation Market for DNA Sequencing, $Million, 2018-2025
  • Figure 9.3: NGS Sample Preparation Market for Whole-Genome Sequencing, $Million , 2018-2025
  • Figure 9.4: NGS Sample Preparation Market for RNA Sequencing, $Million ,2018-2025
  • Figure 9.5: NGS Sample Preparation Market for Methylation Sequencing, $Million ,2018-2025
  • Figure 9.6: NGS Sample Preparation Market for Metagenomics, $Million ,2018-2025
  • Figure 9.7: NGS Sample Preparation Market for Single Cell Sequencing, $Million, 2018-2025
  • Figure 9.8: NGS Sample Preparation Market for Other Applications, $Million, 2018-2025
  • Figure 10.1: NGS Sample Preparation Market, By End-User, $Million, 2019 and 2025
  • Figure 10.2: NGS Sample Preparation Market for Hospital and Clinics, $Million, 2018-2025
  • Figure 10.3: NGS Sample Preparation Market for Academic and Research Institutes, $Million, 2018-2025
  • Figure 10.4: NGS Sample Preparation Market for Pharmaceutical & Biotechnology Companies, $Million, 2018-2025
  • Figure 10.5: NGS Sample Preparation Market for Other End-Users, $Million, 2018-2025
  • Figure 11.1: NGS Sample Preparation Market (by Region), $Million, 2019 and 2025
  • Figure 11.2: NGS Sample Preparation Market (by Region), $Million, 2018-2025
  • Figure 11.3: North America: Market Dynamics
  • Figure 11.4: North America NGS Sample Preparation Market (by Country), $Million, 2018-2025
  • Figure 11.5: U.S. NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.6: U.S. NGS Sample Preparation Market, by Product, $Million, 2018-2025
  • Figure 11.7: U.S. NGS Sample Preparation Market, by Automated Workstation, $Million, 2018-2025
  • Figure 11.8: U.S. NGS Sample Preparation Market, by Instrument, $Million, 2018-2025
  • Figure 11.9: U.S. NGS Sample Preparation Market, by Consumables, $Million, 2018-2025
  • Figure 11.10: Canada NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.11: Europe: Market Dynamics
  • Figure 11.12: Europe NGS Sample Preparation Market, By Country, $Million, 2018-2025
  • Figure 11.13: Germany NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.14: France NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.15: U.K. NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.16: Italy NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.17: Spain NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.18: The Netherlands NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.19: Russia NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.20: Rest-of-Europe NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.21: APAC: Market Dynamics
  • Figure 11.22: Asia-Pacific NGS Sample Preparation Market, By Country, $Million, 2018-2025
  • Figure 11.23: China NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.24: Japan NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.25: Australia NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.26: India NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.27: Rest-of-APAC NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.28: Latin America: Market Dynamics
  • Figure 11.29: Latin America NGS Sample Preparation Market, By Country, $Million, 2018-2025
  • Figure 11.30: Brazil NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.31: Mexico NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.32: Rest-of-Latin-America NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 11.33: Middle East and Africa: Market Dynamics
  • Figure 11.34: Middle East and Africa NGS Sample Preparation Market, $Million, 2018-2025
  • Figure 12.1: Market Share Analysis for the Global NGS Sample Preparation Market, 2018
  • Figure 12.2: NGS Sample Preparation Heat Map (by Product)
  • Figure 12.3: Growth Share Matrix for Global NGS Sample Preparation Market (by End User), 2018
  • Figure 12.4: Growth Share Matrix for Global NGS Sample Preparation Market (by Region), 2018
  • Figure 12.5: Growth Share Matrix for Global NGS Sample Preparation Market (by Product), 2018
  • Figure 13.1: Growth Share Matrix for Global NGS Sample Preparation Market (Top 5), 2018
  • Figure 13.2: Business Expansion Opportunity Mapping (by Product)
  • Figure 13.3: Business Expansion Opportunity Mapping (by Region)
  • Figure 13.4: NGS Sample Preparation Market: SWOT Analysis
  • Figure 14.1: Agilent Technologies: Product Portfolio
  • Figure 14.2: Agilent Technologies: Overall Financials, 2016-2018
  • Figure 14.3: Agilent Technologies: Revenue (by Segment), 2016-2018
  • Figure 14.4: Agilent Technologies: Revenue (by Region), 2016-2018
  • Figure 14.5: Agilent Technologies: R&D Expenditure, 2016-2018
  • Figure 14.6: Agilent Technologies: SWOT Analysis
  • Figure 14.7: Aurora Biomed Inc.: Overall Product Portfolio
  • Figure 14.8: Aurora Biomed Inc.: SWOT Analysis
  • Figure 14.9: Bio-Rad Laboratories, Inc.: Product Offerings
  • Figure 14.10: Bio-Rad Laboratories, Inc.: Overall Financials, 2016-2018
  • Figure 14.11: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2016-2018
  • Figure 14.12: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2016-2018
  • Figure 14.13: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2016-2018
  • Figure 14.14: Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 14.15: Danaher Corporation: Product Portfolio
  • Figure 14.16: Danaher Corporation: Overall Financials, 2016-2018
  • Figure 14.17: Danaher Corporation: Revenue (by Business Segment), 2016-2018
  • Figure 14.18: Danaher Corporation: Revenue (by Region), 2016-2018
  • Figure 14.19: Danaher Corporation: R&D Expenditure, 2016-2018
  • Figure 14.20: Danaher Corporation: SWOT Analysis
  • Figure 14.21: Eppendorf AG: Overall Product Portfolio
  • Figure 14.22: Eppendorf AG: Overall Financials, 2016-2018
  • Figure 14.23: Eppendorf AG: Revenue (by Region), 2016-2018
  • Figure 14.24: Eppendorf AG: R&D Expenditure, 2016-2018
  • Figure 14.25: Eppendorf AG: SWOT Analysis
  • Figure 14.26: F. Hoffmann-La Roche AG: Product Offerings
  • Figure 14.27: F. Hoffmann-La Roche Ltd: Overall Financials, 2016-2018
  • Figure 14.28: F. Hoffmann-La Roche Ltd: Sales (by Segment), 2016-2018
  • Figure 14.29: F. Hoffmann-La Roche Ltd: Sales (by Region), 2016-2018
  • Figure 14.30: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2016-2018
  • Figure 14.31: F. Hoffmann-La Roche Ltd: SWOT Analysis
  • Figure 14.32: Hamilton Company: Overall Product Portfolio
  • Figure 14.33: Hamilton Company: SWOT Analysis
  • Figure 14.34: Product Portfolio: Illumina, Inc.
  • Figure 14.35: Illumina, Inc.: Overall Financials, 2016-2018
  • Figure 14.36: Illumina, Inc.: Revenue (by Segment), 2016-2018
  • Figure 14.37: Illumina, Inc.: Revenue (by Region), 2016-2018
  • Figure 14.38: Illumina, Inc.: R&D Expenditure, 2016-2018
  • Figure 14.39: Illumina, Inc.: SWOT Analysis
  • Figure 14.40: New England Biolabs, Inc: Product Offerings
  • Figure 14.41: New England Biolabs, Inc.: SWOT Analysis
  • Figure 14.42: Oxford Nanopore Technologies Limited: Product Offerings
  • Figure 14.43: Oxford Nanopore Technologies Limited: SWOT Analysis
  • Figure 14.44: PerkinElmer, Inc.: Product Portfolio
  • Figure 14.45: Perkin Elmer, Inc.: Overall Financials, (2016-2018)
  • Figure 14.46: Perkin Elmer, Inc.: Revenue (by Business Segment), 2016-2018
  • Figure 14.47: Perkin Elmer, Inc.: Revenue (by Region), 2016-2018
  • Figure 17.48: PerkinElmer, Inc.: R&D Expenditure, 2016-2018
  • Figure 14.49: PerkinElmer, Inc.: SWOT Analysis
  • Figure 14.50: Promega Corporation: Overall Product Portfolio
  • Figure 14.51: Promega Corporation: SWOT Analysis
  • Figure 14.52: QIAGEN N.V.: Overall Product Portfolio
  • Figure 14.53: QIAGEN N.V.: Overall Financials, 2016-2018
  • Figure 14.54: QIAGEN N.V.: Revenue (by Segment), 2016-2018
  • Figure 14.55: QIAGEN N.V.: Revenue (by Region), 2016-2018
  • Figure 14.56: QIAGEN N.V.: R&D Expenditure, 2016-2018
  • Figure 14.57: QIAGEN N.V.: SWOT Analysis
  • Figure 14.58: Swift Biosciences Inc.: Overall Product Portfolio
  • Figure 14.59: Swift Biosciences Inc.: SWOT Analysis
  • Figure 14.60: Product Portfolio: Tecan Group
  • Figure 14.61: Tecan Group: Overall Financials, 2016-2018
  • Figure 14.62: Tecan Group Revenue (by Segment), 2016-2018
  • Figure 14.63: Tecan Group: Revenue (by Region), 2016-2018
  • Figure 14.64: Tecan Group: R&D Expenditure, 2016-2018
  • Figure 14.65: Tecan Group: SWOT Analysis
  • Figure 14.66: Thermo Fisher Scientific Inc.: Product Portfolio
  • Figure 14.67: Thermo Fisher Scientific Inc.: Overall Financials, 2016-2018
  • Figure 14.68: Thermo Fisher Scientific Inc.: Revenue (by Segment), 2016-2018
  • Figure 14.69: Thermo Fisher Scientific Inc.: Revenue (by Region), 2016-2018
  • Figure 14.70: Thermo Fisher Scientific Inc.: R&D Expenditure, 2016-2018
  • Figure 14.71: Thermo Fisher Scientific Inc.: SWOT Analysis
目次
Product Code: BH170A

"Global NGS Sample Preparation Market to Grow at a CAGR of 15.54% from 2019-2025."

Key Questions Answered in this Report:

  • What are the major market drivers, challenges, and opportunities in the global NGS sample preparation market?
  • What are the underlying structures resulting in the emerging trends within the global NGS sample preparation market?
  • How is each segment expected to grow in the global NGS sample preparation market during the forecast period and what is the estimated revenue to be generated by each of the segments by the end of 2025?
  • What are the key developmental strategies which are implemented by the major players in order to sustain in the competitive market? What are the key regulatory implications in developed and developing regions for NGS sample preparation?
  • Who are the leading players with significant offerings to the global NGS sample preparation market? What is the current market dominance for each of these leading players?
  • What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2019-2025?
  • What are the key applications in global NGS sample preparation market? What are the major segments of these applications?
  • Which are the dominant therapeutic areas of the global NGS sample preparation market? Which is the fastest growing therapeutic area in the global NGS sample preparation market?
  • Who are the key manufacturers and service providers in the global NGS sample preparation market, and what are their contributions? What is the growth potential of each major NGS sample preparation provider?
  • What is the scope of the global NGS sample preparation market in North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa?

Global NGS Sample Preparation Market Forecast, 2019-2025

The NGS sample preparation industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.54% during the forecast period, 2019-2025. The NGS sample preparation market generated $1,140.0 million revenue in 2018, in terms of value.

The NGS sample preparation market growth has been primarily attributed to the major drivers in this market such as rising prevalence of genetic disorders and infectious diseases, increasing direct-to-consumer genetic testing, and increasing research in the field of genomics. However, there are significant challenges which are restraining the market growth. These challenges include cost constraints pertaining to automated NGS sample preparation affecting adoption, lack of high complexity genetic testing centers, and regulatory uncertainty.

Expert Quote

"The development of automated sample preparation equipment and consumables has achieved huge success over the past year with automated workstations and specialized kits now available across major regions proving the potential of these equipment to lower cost and ease sequencing research around the globe."

Scope of the Market Intelligence on NGS Sample Preparation Market

The NGS sample preparation research provides a holistic view of the market in terms of various factors influencing it, including product optimization, and technological advancements.

The scope of this report is centered upon conducting a detailed study of the products and manufacturers allied with the market. In addition, the study also includes exhaustive information on the unmet needs, perception on the new products, competitive landscape, market share of leading manufacturers, growth potential of each underlying sub-segment, and company, as well as other vital information with respect to global NGS sample preparation market.

Market Segmentation

The NGS sample preparation market segmentation (on the basis of product) is further segmented into workstations, standalone equipment, consumables, accessories.

The NGS sample preparation market segmentation (on the basis of application) is segmented into DNA sequencing, whole-genome sequencing, RNA sequencing, methylation sequencing, metagenomics, single cell sequencing, and others.

The NGS sample preparation market segmentation (on the basis of therapeutic area) is segmented into oncology, human genetics/population genetics, prenatal/neonatal, infectious diseases, and others.

The NGS sample preparation market segmentation (on the basis of end user) is segmented into hospitals and clinics, academic research institutes, pharmaceutical and biotechnology companies, and others.

Key Companies in the NGS sample preparation market

The key manufacturers who have been contributing significantly to the NGS sample preparation market include: Agilent Technologies, Inc., Aurora Biomed Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Eppendorf AG, F. Hoffmann-La Roche AG, Hamilton Company, Illumina, Inc., New England Biolabs, Inc., Tecan Trading AG, Oxford Nanopore Technologies Limited, PerkinElmer Inc., Promega Corporation, QIAGEN N.V., Swift Biosciences Inc., Thermo Fisher Scientific, Inc., among others.

Table of Contents

Executive Summary

1. Research Scope and Methodology

  • 1.1. Scope of the Study
  • 1.2. Research Methodology
  • 1.3. Data Sources
  • 1.4. Assumptions and Limitations
  • 1.5. Data and Prediction Modelling

2. Market Overview

  • 2.1. The Basic NGS Workflow
  • 2.2. Global NGS Sample Preparation Market Scenario

3. Market Dynamics

  • 3.1. Drivers
    • 3.1.1. Short Term Driver
      • 3.1.1.1. Rising Prevalence of Genetic Disorders
    • 3.1.2. Current Drivers
      • 3.1.2.1. Increasing Direct-to-Consumer Genetic Testing
      • 3.1.2.2. Rising Prevalence of Infectious Diseases
    • 3.1.3. Long Term Driver
      • 3.1.3.1. Increasing Research Funding in the Field of Genomics
  • 3.2. Restraints
    • 3.2.1. Short Term Restraint
      • 3.2.1.1. High Cost of Automated NGS Sample Preparation Instruments
    • 3.2.2. Current Restraint
      • 3.2.2.1. Lack of Advanced Genetic Testing Centers
    • 3.2.3. Long Term Restraint
      • 3.2.3.1. Stringent Regulatory Standards
  • 3.3. Market Opportunities
    • 3.3.1. Adoption of Automated NGS Sample Preparation in the Emerging Markets
    • 3.3.2. Technological Advancements in NGS Sample Preparation
    • 3.3.3. Opportunity (by Product)
      • 3.3.3.1. Workstations
      • 3.3.3.2. Consumables
    • 3.3.4. Opportunity (by Application)
      • 3.3.4.1. DNA Sequencing
      • 3.3.4.2. Metagenomics
    • 3.3.5. Opportunity (by Region)
      • 3.3.5.1. North America
      • 3.3.5.2. APAC

4. Automated NGS Sample Preparation Market: Industry Insights

  • 4.1. Key Developments
    • 4.1.1. Product Launch
    • 4.1.2. Collaborations, Partnerships and Agreements:
    • 4.1.3. Product Enhancements
    • 4.1.4. Acquisitions
    • 4.1.5. Business Expansions
  • 4.2. Industry Trends
    • 4.2.1. Preference for Automated NGS Sample Preparation Workstations Integrated with QC (Quality Control)
    • 4.2.2. Growing Trend for the Preference of Customized Automated NGS Sample Preparation Platform

5. Next-Generation Sequencing Sample Preparation Market, End-User & Pricing Analysis

  • 5.1. Satisfaction Level of Different Instruments (by Brand)
  • 5.2. Pricing Analysis of Preferred Products- Step Wise (Sample Quantification, Library Preparation, Target Enrichment, Library Quantification)
  • 5.3. Pricing Analysis - Accessories and Components
  • 5.4. Pricing Analysis - Consumables

6. NGS Sample Preparation Market (by Product)

  • 6.1. Automated Workstations
    • 6.1.1. Open Systems
    • 6.1.2. Closed Systems
  • 6.2. Standalone Automation Instruments
    • 6.2.1. Fragment Analyzer
    • 6.2.2. Ultrasonicator/ Sonicator
    • 6.2.3. DNA/RNA Shearing Instruments
    • 6.2.4. Template Preparation Instruments
    • 6.2.5. DNA Selection Instruments
    • 6.2.6. Nucleic Acid Extraction/Isolation System
  • 6.3. Consumables
    • 6.3.1. Sample Extraction and Isolation Kits
    • 6.3.2. Sample Purification Kits
    • 6.3.3. Library Preparation Kits
      • 6.3.3.1. DNA Library Preparation Kits
      • 6.3.3.2. RNA Library Preparation Kits
      • 6.3.3.3. FFPE DNA Kits
      • 6.3.3.4. ChIP-Seq Library Preparation
      • 6.3.3.5. Library Quantitation
      • 6.3.3.6. Library Amplification
      • 6.3.3.7. Library Preparation Accessories
    • 6.3.4. Clean-up and Selection Kits
    • 6.3.5. Target Enrichment Kits
    • 6.3.6. Microbiome DNA Enrichment
    • 6.3.7. Other Consumables
  • 6.4. Accessories and Components

7. NGS Sample Preparation Market (by Workflow)

  • 7.1. Sample Extraction/Isolation
  • 7.2. Sample Quantification
  • 7.3. Quality Control
  • 7.4. Fragmentation
  • 7.5. Library preparation
  • 7.6. Target Enrichment
  • 7.7. Library Quantification
  • 7.8. Pooling

8. NGS Sample Preparation Market (by Therapeutic Area)

  • 8.1. Oncology
  • 8.2 Human Genetics/Population Genetics
  • 8.3. Prenatal/Neonatal
  • 8.4. Infectious Diseases
  • 8.5 Other Therapeutic Areas

9. NGS Sample Preparation Market (by Application)

  • 9.1. DNA Sequencing
  • 9.2. Whole-Genome Sequencing
  • 9.3. RNA Sequencing
  • 9.4. Methylation Sequencing
  • 9.5. Metagenomics
  • 9.6. Single Cell Sequencing
  • 9.7. Others

10. NGS Sample Preparation Market (by End-User)

  • 10.1. Hospitals and Clinics
  • 10.2. Academic and Research Institutes
  • 10.3. Pharmaceutical and Biotechnology Companies
  • 10.4. Other End-Users

11. NGS Sample Preparation Market (by Region)

  • 11.1. Overview
  • 11.2. North America
    • 11.2.1. U.S.
    • 11.2.2. Canada
  • 11.3. Europe
    • 11.3.1. Germany
    • 11.3.2. France
    • 11.3.3. U.K.
    • 11.3.4. Italy
    • 11.3.5. Spain
    • 11.3.6. Netherlands
    • 11.3.7. Russia
    • 11.3.8. Rest-of-Europe
  • 11.4. Asia-Pacific
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. Australia
    • 11.4.4. India
    • 11.4.5. Rest-of-Asia-Pacific
  • 11.5. Latin America
    • 11.5.1. Brazil
    • 11.5.2. Mexico
    • 11.5.3. Rest-of-Latin-America
  • 11.6. Middle East and Africa

12. Competitive Landscape

  • 12.1. Market Share Analysis
  • 12.2. Product Benchmarking
  • 12.3. Growth Share Analysis by End-User
  • 12.4. Growth Share Analysis by Region
  • 12.5. Growth Share Analysis by Product

13. Strategic Recommendations

  • 13.1. Key Takeaways
  • 13.2. Benchmarking Roche, Qiagen and Illumina Position in NGS Sample Preparation Market
  • 13.3. Gap Analysis
  • 13.4. Business Expansion Opportunity Mapping
    • 13.4.1. By Product
    • 13.4.2. By Region
  • 13.5. Investment Opportunities
  • 13.6. SWOT Analysis
  • 13.7. Propitious Strategies to Succeed in NGS Sample Preparation Market
    • 13.7.1. Optimizing Existing Products for Existing Customers
    • 13.7.2. Expanding into Niche Applications

14. Company Profiles

  • 14.1. Agilent Technologies
    • 14.1.1. Company Overview
    • 14.1.2. Role of Agilent Technologies in the Global NGS Sample Preparation Market
    • 14.1.3. Financials
    • 14.1.4. Key Insights about Financial Health of the Company
    • 14.1.5. SWOT Analysis
  • 14.2. Aurora Biomed Inc.
    • 14.2.1. Company Overview
    • 14.2.2. Role of Aurora Biomed Inc. in the Global NGS Sample Preparation Market
    • 14.2.3. SWOT Analysis
  • 14.3. Bio-Rad Laboratories, Inc.
    • 14.3.1. Company Overview
    • 14.3.2. Role of Bio-Rad Laboratories, Inc. in the Global NGS Sample Preparation Market
    • 14.3.3. Financials
    • 14.3.4. Key Insights about Financial Health of the Company
    • 14.3.5. SWOT Analysis
  • 14.4. Danaher Corporation
    • 14.4.1. Company Overview
    • 14.4.2. Role of Danaher Corporation in the Global NGS Sample Preparation Market
    • 14.4.3. Financials
    • 14.4.4. Key Insights about Financial Health of the Company
    • 14.4.5. SWOT Analysis
  • 14.5. Eppendorf AG
    • 14.5.1. Company Overview
    • 14.5.2. Role of Eppendorf AG in the NGS Sample Preparation Market
    • 14.5.3. Financials
    • 14.5.4. Key Insights about Financial Health of the Company
    • 14.5.5. SWOT Analysis
  • 14.6. F. Hoffmann-La Roche Ltd
    • 14.6.1. Company Overview
    • 14.6.2. Role of Roche in the Global NGS Sample Preparation Market
    • 14.6.3. Financials
    • 14.6.4. Key Insights about Financial Health of the Company
    • 14.6.5. SWOT Analysis
  • 14.7. Hamilton Company
    • 14.7.1. Company Overview
    • 14.7.2. Role of Hamilton Company in the global NGS Sample Preparation Market
    • 14.7.3. SWOT Analysis
  • 14.8. Illumina, Inc.
    • 14.8.1. Company Overview
    • 14.8.2. Role of Illumina, Inc. in the global NGS Sample Preparation Market
    • 14.8.3. Financials
    • 14.8.4. Key Insights about Financial Health of the Company
    • 14.8.5. SWOT Analysis
  • 14.9. New England Biolabs, Inc
    • 14.9.1. Company Overview
    • 14.9.2. Role of New England Biolabs, Inc. in the Global NGS Sample Preparation Market
    • 14.9.3. SWOT Analysis
  • 14.10 Oxford Nanopore Technologies Limited
    • 14.10.1. Company Overview
    • 14.10.2. Role of Oxford Nanopore Technologies Limited in the Global NGS Sample Preparation Market
    • 14.10.3. SWOT Analysis
  • 14.11 PerkinElmer, Inc.
    • 14.11.1. Company Overview
    • 14.11.2. Role of PerkinElmer, Inc. in the NGS Sample Preparation Market
    • 14.11.3. Financials
    • 14.11.4. SWOT Analysis
  • 14.12 Promega Corporation
    • 14.12.1. Company Overview
    • 14.12.2. Role of Promega Corporation in the Global NGS Sample Preparation Market
    • 14.12.3. SWOT Analysis
  • 14.13 QIAGEN N.V.
    • 14.13.1. Company Overview
    • 14.13.2. Role of QIAGEN N.V. in the NGS Sample Preparation Market
    • 14.13.3. Financials
    • 14.13.4. Key Insights about Financial Health of the Company
    • 14.13.5. SWOT Analysis
  • 14.14 Swift Biosciences Inc.
    • 14.14.1. Company Overview
    • 14.14.2. Role of Swift Biosciences Inc. in the Global NGS Sample Preparation Market
    • 14.14.3. SWOT Analysis
  • 14.15 Tecan Group
    • 14.15.1. Company Overview
    • 14.15.2. Role of Tecan Group in the Global NGS Sample Preparation Market
    • 14.15.3. Financials
    • 14.15.4. Key Insights about Financial Health of the Company
    • 14.15.5. SWOT Analysis
  • 14.16 Thermo Fisher Scientific Inc.
    • 14.16.1. Company Overview
    • 14.16.2. Role of Thermo Fisher Scientific Inc. in the Global NGS Sample Preparation Market
    • 14.16.3. Financials
    • 14.16.4. Key Insights about Financial Health of the Company
    • 14.16.5. SWOT Analysis
Back to Top